Profile image
Story Views

Last Hour:
Last 24 Hours:

Seborrhea – Pipeline Review, H1 2017

Monday, March 20, 2017 3:10
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Ethocle Reports has published its latest Market Research Report on Seborrhea – Pipeline Review, H1 2017. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 2, 2 and 2 respectively. Browse market data tables and figures.


                                                                                                                    Published On: 15-Mar-2017 | Pages: 39


Pharmaceutical and Healthcare disease pipeline guide Seborrhea – Pipeline Review, H1 2017, provides an overview of the Seborrhea (Dermatology) pipeline landscape.

Seborrhea is form of skin eczema that mainly affects scalp, ears, face, chest, and folds of skin. Symptoms include skin flakes, red skin, itching and skin lesions. Risk factors include stress or fatigue, skin acne and obesity. Treatment includes antifungal medications.

Capture.PNG    d.PNG    dd.PNG

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Seborrhea – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Seborrhea (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


- The pipeline guide provides a snapshot of the global therapeutic landscape of Seborrhea (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Seborrhea (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Seborrhea (Dermatology).

- Classify potential new clients or partners in the target demographic.

Table of Contents


Global Markets Direct Report Coverage

Seborrhea – Overview

Seborrhea – Therapeutics Development

Products under Development by Companies

Seborrhea – Therapeutics Assessment

Assessment by Target

Seborrhea – Companies Involved in Therapeutics Development

Aclaris Therapeutics Inc

Seborrhea – Drug Profiles

R&D Progress

hydrogen peroxide – Drug Profile

Product Description

Mechanism Of Action


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.